Serum markers for prognostic value of EGFR-TKI in lung adenocarcinoma with bone metastases: a retrospective study
Background Lung adenocarcinoma is a prevalent malignancy. Mutations in the epidermal growth factor receptor (EGFR) have introduced novel prospects for targeted therapies. However, the status of EGFR mutations alone may be insufficient to fully predict treatment outcomes. To this end, the present res...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
PeerJ Inc.
2026-01-01
|
| Col·lecció: | PeerJ |
| Matèries: | |
| Accés en línia: | https://peerj.com/articles/20537.pdf |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|